Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $6.47 and traded as low as $5.00. Mannatech shares last traded at $5.17, with a volume of 4,559 shares.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings cut shares of Mannatech from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 11th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Mannatech has a consensus rating of “Sell”.
Read Our Latest Stock Analysis on MTEX
Mannatech Price Performance
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its quarterly earnings results on Thursday, May 14th. The company reported $0.49 earnings per share for the quarter. The business had revenue of $24.92 million for the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 11.97%.
Insider Buying and Selling
In other Mannatech news, Director Kevin Andrew Robbins bought 7,100 shares of the stock in a transaction on Tuesday, May 19th. The shares were bought at an average price of $4.17 per share, with a total value of $29,607.00. Following the purchase, the director directly owned 33,333 shares in the company, valued at $138,998.61. The trade was a 27.07% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In the last three months, insiders bought 14,903 shares of company stock worth $62,155. Company insiders own 41.50% of the company’s stock.
About Mannatech
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Featured Articles
- Five stocks we like better than Mannatech
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
